Swedish (OMX) Growth Healthcare Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Feb 08, 2026

Discover Swedish Healthcare Growth Stocks that are on the OMX. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.

83 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
KONT	SEK 2.09	-9.1%	-18.4%	SEK 73.7m	SEK 4.50	1.9	134.9%	n/a
ICO	SEK 1.12	-2.2%	-74.2%	SEK 83.4m	SEK 4.45	5.0	123.9%	n/a
BACTI B	SEK 16.40	-2.4%	-46.4%	SEK 574.7m	SEK 31.50	2.5	114.9%	n/a
BOUL	SEK 5.00	-7.4%	-42.5%	SEK 194.2m	SEK 7.50	1.2	113.1%	0%
INTEG B	SEK 8.79	-9.9%	-48.3%	SEK 234.4m	n/a	2.3	112.9%	n/a
PAX	SEK 45.00	-1.5%	-35.3%	SEK 1.0b	SEK 100.00	219.8	112.9%	n/a
MNTC	SEK 13.60	-0.7%	-46.9%	SEK 382.5m	SEK 17.25	1.4	107.2%	0%
CLS B	SEK 7.65	-1.9%	104.5%	SEK 238.4m	SEK 13.50	11.2	98.0%	n/a
BRAIN	SEK 0.45	-3.2%	-65.4%	SEK 177.7m	SEK 1.00	3.9	97.2%	n/a
ADDV A	SEK 1.72	0.6%	-71.6%	SEK 1.0b	n/a	242.4	81.5%	0%
ACARIX	SEK 0.28	16.9%	13.1%	SEK 347.4m	n/a	50.2	79.3%	n/a
SEDANA	SEK 9.94	-0.5%	-47.1%	SEK 987.4m	SEK 19.00	5.0	78.4%	n/a
OSSD	SEK 6.48	-33.2%	-49.4%	SEK 716.9m	SEK 12.75	4.0	66.7%	n/a
EQL	SEK 61.60	-4.2%	-26.3%	SEK 1.8b	SEK 80.00	62.0	66.3%	n/a
CARA	SEK 24.00	-5.7%	2.5%	SEK 1.7b	SEK 35.50	5.1	66.1%	0%
XVIVO	SEK 201.00	-6.8%	-57.4%	SEK 6.3b	SEK 301.00	251.6	56.7%	n/a
SYNT	SEK 27.70	0%	-13.4%	SEK 1.2b	SEK 30.00	115.3	47.4%	0%
CRAD B	SEK 31.60	-0.9%	-1.6%	SEK 1.1b	SEK 38.00	45.6	43.8%	n/a
SEZI	SEK 4.69	-4.6%	-19.9%	SEK 736.6m	SEK 12.00	8.2	42.0%	n/a
VIMIAN	SEK 26.62	0%	-33.4%	SEK 14.1b	SEK 33.76	42.0	40.8%	n/a
ORT B	SEK 13.25	-1.1%	55.5%	SEK 491.4m	SEK 31.50	6.1	37.3%	n/a
SCIB	SEK 0.27	-2.2%	-29.5%	SEK 109.8m	n/a	3.0	36.2%	n/a
STIL	SEK 150.00	-16.4%	-34.8%	SEK 1.3b	SEK 227.00	32.3	31.7%	0%
IMMNOV	SEK 0.19	-3.8%	-56.9%	SEK 125.9m	n/a	160.2	29.1%	n/a

Page 1 of 4